2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Ciceri Fabio: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole Conditioning treatment "Thiotepa-Treosulfan-Fludarabine", PBSC graft, GvHD prophylaxis - Transplant-Related Hematologic Malignancy, Leukemia, Acute | Phase 2 | Completed | Ciceri Fabio | 10 | 2018-06-18 | 2022-07-19 |
| Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant Fludarabine, ARA-C, Treosulfan - Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 2 | Completed | Ciceri Fabio | 15 | 2009-02-10 | 2023-11-18 |
Myelodysplastic Syndromes (2) · Graft vs Host Disease (1) · Leukemia (1) · Leukemia, Myeloid, Acute (1) · Mycoses (1)
Cytarabine (1) · Peripheral Blood Stem Cell Transplantation (1) · fludarabine (1) · treosulfan (1)
Italy (2)
Fabio Ciceri, MD (1)
2008 (1), 2017 (1)